Monthly recap #5
An update on a previously discussed company, and other news from January
HBM Healthcare Investments
Since the original post one year ago, $HBMN.SW is up a cumulative +26% (with +21% from price appreciation and +5% from dividends), with a significant move in January (+13%) following the Q3 results.
Indeed, on Jan 20 HBM published the results for the first 9 months of 2024 (to December 2024 as fiscal year end is March): it gene…